Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 12 May 2017, 08:38 HKT/SGT

Source: Ausnutria Dairy Corporation Ltd
Ausnutria Announces 2017 First Quarter Results
- Revenue and Profit Attributable to Equity Holders Increased YoY 30.3% and 22.5% Respectively;
- The sales of own brands infant formula continue to grow;
- The sales of goat milk-based infant formula recorded new highs

HONG KONG, May 12, 2017 - (ACN Newswire) - Ausnutria Dairy Corporation Ltd ("Ausnutria" or the "Company", together with its subsidiaries, the "Group"; stock code: 1717.HK), a leading dairy industry company with production facilities principally based in the PRC, the Netherlands and Australia, is engaged in the production and distribution of all dairy products (including infant formula) and nutrition products. Today, the Group announced its unaudited consolidated first quarter results for the three months ended 31 March 2017 (the "period under review").

For the period under review, the Group recorded revenue of approximately RMB751.3 million, representing an increase of approximately RMB174.8 million or 30.3% compared with the corresponding period in 2016. The Group's profit attributable to equity holders of the Company amounted to approximately RMB65.0 million, an increase of approximately RMB11.9 million or 22.5%, compared to the corresponding period in 2016. Excluding the impact of the new nutrition products business, which commenced in the fourth quarter of 2016 and still at its start-up stage with an operating loss of RMB4.6 million.

The Group's profit attributable to equity holders in the first quarter of 2017 amounted to RMB69.6 million, an increase of RMB16.5 million or 31.1% as compared with the same period in 2016. The improvement in financial performance is primarily attributable to the continuous increase in sale of the Group's own-branded infant formula products which was mainly driven by the continuous stable increase in demand for infant formula in the PRC; the increasing recognition of the high quality standards of infant formula manufactured by the Group; the clear brand positioning implemented by the Group; and the continuous extension of the sales network and the improvements of services provided to the customers.

Aided by the benefits resulting from above factors, sale of own-brand goat milk-based and cow milk-based infant formulae continued to grow. As a result, the Group achieved expected operating results during the period under review. The sales of own brand goat milk-based infant formula in the PRC achieved RMB220.6 million, dramatically increasing by 72.7% compared with the corresponding period in 2016. Moreover, the sales of the own brand cow milk-based infant formula in the PRC reached RMB256.9 million, representing an increase of 26.1% year on year.

To cater for the changing market environment and take full advantage of the market opportunities brought by "One Belt, One Road" strategy, the Group made further improvements to its upstream industrial chain and started construction of the new factories in the Netherlands and New Zealand to meet the increasing market demands. The new factories have already been substantially completed, with equipment installation and start of production slated to begin in 2017. The Group believes that the productivity and quality standards and in turn the turnover and profitability will be further enhanced once the new factories commences operation sometime in the future.

Mr. Yan Weibin, Chairman of the Group, said, "2017 marks the second year of our Group advancing into the 'Ausnutria Golden Decade' strategy. In accordance with established plans, the Group will continue to accelerate research and development progress, construction of the upstream supply chain. We achieved healthy growth in our core businesses, the infant formula milk powder, and our new nutrition products business.

The demand for infant formula in the PRC continues to show steady growth. The market shows tremendous potential, and we have gained significant recognition from the market and consumers with our high quality infant formula. We firmly believe that with our clear brand positioning, sales of the own brand infant formula will continue to increase. This will bolster further growth in performance, and maximize the company's value for our shareholders and consumers."

May 12, 2017 08:38 HKT/SGT
Topic: Press release summary
Sectors: Investors/Exchanges, Daily Finance, Food/Beverage
From the Asia Corporate News Network

Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Ausnutria Dairy Corporation Ltd
Dec 6, 2018 19:26 HKT/SGT
Representatives of CITIC Agri Fund and A Veteran Specialized in Dairy Industry in ANZ Region Joined the Board of Directors, Enhances the development of the 'Golden Decade' of Ausnutria
Nov 2, 2018 19:14 HKT/SGT
Continuous Growth for 3Q 2018 Results; Ausnutria Announces the Positive Profit Alert for Nine Consecutive Times
Oct 29, 2018 16:50 HKT/SGT
Ausnutria wins the Bronze Award in the International Galaxy Awards
Oct 25, 2018 21:56 HKT/SGT
Investment from CITIC Agri Fund Completed; Development of Ausnutria Further Motivated
Oct 10, 2018 22:53 HKT/SGT
Ausnutria Announces the Proposed Introduction of CITIC Agri Fund Passed by a Majority Vote at the EGM
Aug 15, 2018 08:50 HKT/SGT
Ausnutria Records New Highs in 1H 2018
Aug 1, 2018 19:45 HKT/SGT
Interim Results for 2018 Continues to Record a Significant Growth, Ausnutria Dairy Announces the Positive Profit Alert for Eight Consecutive Times
June 29, 2018 19:24 HKT/SGT
Ausnutria Increase in Stake by Chairman and Senior Management
Mar 27, 2018 23:06 HKT/SGT
Ausnutria 2017 Annual Results - Revenue and Profit Increase 43.3% and 44.9%
Aug 14, 2017 09:55 HKT/SGT
In the Second Year of its 'Golden Decade' Strategy, Ausnutria Records New Highs in 1H 2017
More news >>
 News Alerts
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: